TSX/GUD (TSX/GUD)

Toronto Stock Exchange: TSX/GUD · CAD

CA$11.4

+0.04 (+0.3%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	547.3M
Net income (ttm)	14.9M
EPS (ttm)	CA$0.15
Shares out	98.2M
P/E (trailing)	75.7x
P/E (forward)	92.7x
Volume	39,538
Beta	-0.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 547.3M
Net income (ttm): 14.9M
EPS (ttm): CA$0.15
P/E (trailing): 75.7x
P/E (forward): 92.7x
Market cap: 1.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E92.7

P25 n/aP50 n/aP75 n/a

Trailing P/E75.7

P25 n/aP50 n/aP75 n/a

ROE1.9

P25 n/aP50 n/aP75 n/a

ROIC2.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/GUD indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

CAD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-12
Employees	830
Employees change	85
Employees growth	11.41%
Enterprise value	CAD 1B
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2013
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA4990531069
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	CAD 1.1B
Next earnings date	2026-11-12
Price	CAD 11.35
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	tsx/GUD
Website	https://www.knighttx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	56.1x
Average P/E ratio (10Y)	115x
Earnings yield	1.32%
EV/Earnings	68.87x
EV/EBIT	46.69x
EV/EBITDA	12.05x
EV/FCF	9.28x
EV/Sales	1.87x
FCF / EV yield	10.78%
FCF yield	9.93%
Forward P/E	92.7x
Graham number	5.23866
Graham upside	-53.8%
Industry forward P/E	34.4x
Lynch fair value	CAD 0.75
Lynch upside	-93.39%
P/(FCF - SBC) ratio	10.85x
P/(OCF - SBC) ratio	10.36x
P/B ratio	1.39x
P/E ratio	75.66x
P/FCF ratio	10.07x
P/OCF ratio	9.64x
P/S ratio	2.03x
Price / tangible book value	3.13x
Price/EBITDA ratio	13.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.01%
EBITDA margin	14.83%
Effective tax rate	30.46%
FCF margin	20.16%
Gross margin	47.37%
Operating margin	4.01%
Pretax margin	3.91%
Profit margin	2.72%
Profit per employee	CAD 17,917
Revenue per employee	CAD 659,404
ROA	1.32%
ROA (5Y)	-0.22%
ROCE	2.55%
ROE	1.9%
ROE (5Y)	-0.81%
ROIC	2.14%
ROIC (5Y)	-0.54%
SBC / revenue	1.46%
Tax / revenue	1.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	8,835.08%
EPS growth 10Y	-0.44%
EPS growth 5Y	-19.96%
EPS growth quarters	2
EPS growth years	0
FCF growth	286.27%
FCF growth (Q)	47.22%
FCF growth (QoQ)	-22.66%
FCF growth 3Y	82.3%
FCF growth 5Y	33.32%
Gross profit growth	57.06%
Gross profit growth (Q)	55.28%
Gross profit growth 3Y	21.22%
Gross profit growth 5Y	23.83%
Net income growth	3,782.77%
Net income growth 5Y	-24.06%
Net income growth quarters	2
Net income growth years	0
OCF growth	279.03%
OCF growth (Q)	45.78%
OCF growth (QoQ)	-27.45%
OCF growth 10Y	19.76%
OCF growth 3Y	75.54%
OCF growth 5Y	30.45%
Revenue growth	42.32%
Revenue growth (Q)	34.33%
Revenue growth (QoQ)	-2.85%
Revenue growth 10Y	70.35%
Revenue growth 3Y	18.8%
Revenue growth 5Y	20.85%
Revenue growth quarters	10
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -4.9M
Depreciation and amortization	CAD 59.2M
EBIT	CAD 21.9M
EBITDA	CAD 81.2M
EPS	CAD 0.15
FCF per share	CAD 1.12
Financing cash flow	CAD -102.7M
Free cash flow	CAD 110.4M
Free cash flow minus SBC	CAD 102.4M
Gross profit	CAD 259.3M
Income taxes	CAD 6.5M
Investing cash flow	CAD -488,000
Net borrowing	CAD -84.9M
Net cash flow	CAD 15.7M
Net income	CAD 14.9M
Operating cash flow minus SBC	CAD 107.3M
Operating income	CAD 21.9M
Revenue	CAD 547.3M
Stock-based compensation	CAD 8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.68
Book value per share	CAD 8.13
Debt / EBITDA	0.4
Debt / equity	0.04
Debt / FCF	0.31
Goodwill	CAD 98.5M
Interest coverage	1.98
Long-term assets	CAD 626.4M
Long-term liabilities	CAD 62.8M
Net cash (debt)	CAD 86.9M
Net cash / market cap	7.82%
Net cash growth	644.1%
Net debt / EBITDA	-1.07
Net debt / equity	-0.11
Net debt / FCF	-0.79
Piotroski F-Score	7
Property, plant and equipment	CAD 31.4M
Shareholders' equity	CAD 798.6M
Tangible book value	CAD 355.2M
Tangible book value per share	CAD 3.62
Total assets	CAD 1B
Total cash	CAD 121.2M
Total debt	CAD 34.3M
Total liabilities	CAD 246.2M
WACC	4.74%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	CAD 418.4M
Current liabilities	CAD 183.5M
Current ratio	2.28
Inventory turnover	1.96
Net working capital	CAD 133.5M
Quick ratio	1.45
Working capital	CAD 234.9M
Working capital turnover	2.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.29%
Shareholder yield	1.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	25.14%
10Y return CAGR	2.27%
10Y total return	25.14%
150-day SMA	CAD 9.28
1D price change	0.35%
1M price change	10.52%
1M total return	10.52%
1W price change	-2.99%
1W total return	-2.99%
1Y price change	94.68%
1Y return CAGR	94.77%
1Y total return	94.68%
20-day SMA	CAD 11.03
200-day SMA	CAD 8.50
3M price change	15.35%
3M total return	15.35%
3Y price change	152.78%
3Y return CAGR	36.21%
3Y total return	152.78%
50-day SMA	CAD 10.38
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 11.83
52-week high date	2026-10-22
52-week low	CAD 5.66
52-week low date	2026-01-14
5Y price change	118.69%
5Y return CAGR	16.94%
5Y total return	118.69%
6M price change	53.79%
6M total return	53.79%
All-time high	CAD 11.83
All-time high date	2026-10-22
All-time low	CAD 3.51
All-time low date	2014-03-03
Average true range (ATR)	CAD 0.26
Average volume	62.6K
Beta (1Y)	0.33
Beta (2Y)	0.31
Beta (5Y)	-0.01
Change from 52-week high	-4.06%
Change from 52-week low	100.53%
Change from all-time high	-4.06%
Change from all-time low	223.36%
Change from open	0.09%
Day's gap	0.27%
Dollar volume	CAD 448,756
High price	CAD 11.39
Low price	CAD 11.28
Monthly RSI	84.01
Open price	CAD 11.34
Position in 52-week range	63.64%
Previous close	CAD 11.31
Price vs 150-day SMA	22.31%
Price vs 20-day SMA	2.9%
Price vs 200-day SMA	33.59%
Price vs 50-day SMA	9.36%
Relative volume	0.63
RSI	62.85
Sharpe ratio	2.45
Sharpe ratio (3Y)	1.16
Sharpe ratio (5Y)	0.58
Sortino ratio	4.84
Sortino ratio (3Y)	2.08
Sortino ratio (5Y)	1.12
Volume	39.5K
Weekly RSI	74.38
YTD price change	87.6%
YTD total return	87.6%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60.6M
Shares change (QoQ)	-0.74%
Shares change (YoY)	-1.29%
Shares held by insiders	23.43%
Shares held by institutions	25.28%
Shares outstanding	98.2M

Deeper analysis on TSX/GUD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/GUD report

Is a complete TSX/GUD research report available?

No complete published report is available for tsx/GUD (TSX/GUD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/GUD (TSX/GUD)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/GUD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/GUD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/GUD

Frequently asked questions